147 related articles for article (PubMed ID: 6214446)
61. [Arterial infusion chemotherapy with SMANCS].
Nekohashi T; Maruno J; Sanjou A; Toda G
Nihon Rinsho; 2001 Oct; 59 Suppl 6():629-33. PubMed ID: 11762025
[No Abstract] [Full Text] [Related]
62. [Pathologic study of hepatocellular carcinoma treated by TAI and TAE with SMANCS].
Takayasu K; Iwata R; Furukawa T; Nakanishi Y; Sakamoto M
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():70-2. PubMed ID: 9512691
[No Abstract] [Full Text] [Related]
63. [Comparative studies on the antitumor activities and side effects of segmental SMANCS/Lip-TAE with segmental SMANCS/Lip-TAI for hepatocellular carcinoma].
Matoba M; Okimura T; Yamamoto I
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():73-9. PubMed ID: 9512692
[TBL] [Abstract][Full Text] [Related]
64. Selective targeting of anti-cancer drug and simultaneous image enhancement in solid tumors by arterially administered lipid contrast medium.
Konno T; Maeda H; Iwai K; Maki S; Tashiro S; Uchida M; Miyauchi Y
Cancer; 1984 Dec; 54(11):2367-74. PubMed ID: 6093980
[TBL] [Abstract][Full Text] [Related]
65. A lipophilic derivative of neocarzinostatin. A polymer conjugation of an antitumor protein antibiotic.
Maeda H; Takeshita J; Kanamaru R
Int J Pept Protein Res; 1979 Aug; 14(2):81-7. PubMed ID: 158571
[TBL] [Abstract][Full Text] [Related]
66. [Arterial infusion of SMANCS for multiple recurrent tumors after hepatic resection].
Takano S; Kono S; Iwai S
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():34-8. PubMed ID: 9512685
[TBL] [Abstract][Full Text] [Related]
67. Passive tumor targeting of soluble macromolecules and drug conjugates.
Seymour LW
Crit Rev Ther Drug Carrier Syst; 1992; 9(2):135-87. PubMed ID: 1386002
[TBL] [Abstract][Full Text] [Related]
68. [Arterial infusion chemotherapy with SMAN CS-Lipiodol for hepatocellular carcinoma evaluation of infusion method].
Takizawa K; Obuchi M; Honda M; Matsuoka S; Shima H; Uchiyama K; Hasebe S; Doai K; Satoh S; Kuniyasu Y
Gan To Kagaku Ryoho; 1997 Nov; 24(14):2117-22. PubMed ID: 9388522
[TBL] [Abstract][Full Text] [Related]
69. Factors and mechanism of "EPR" effect and the enhanced antitumor effects of macromolecular drugs including SMANCS.
Fang J; Sawa T; Maeda H
Adv Exp Med Biol; 2003; 519():29-49. PubMed ID: 12675206
[TBL] [Abstract][Full Text] [Related]
70. [Two cases of long-term survival with hepatocellular carcinoma following targeting therapy with SMANCS/lipiodol].
Inoue Y; Nakamura H
Gan To Kagaku Ryoho; 1996 Jan; 23(1):99-101. PubMed ID: 8546478
[TBL] [Abstract][Full Text] [Related]
71. Absorption, distribution and excretion of neocarzinostatin (NCS) in mice after oral administration.
Toriyama K; Fujita H; Ishida N
J Antibiot (Tokyo); 1975 Jan; 28(1):64-72. PubMed ID: 123896
[TBL] [Abstract][Full Text] [Related]
72. [Use of a lipid lymphographic agent, lipiodol, as a carrier of high molecular weight antitumor agent, smancs, for hepatocellular carcinoma].
Konno T; Maeda H; Yokoyama I; Iwai K; Ogata K; Tashiro S; Uemura K; Mochinaga M; Watanabe E; Nakakuma K; Morinaga T; Miyauchi Y
Gan To Kagaku Ryoho; 1982 Nov; 9(11):2005-15. PubMed ID: 6307179
[TBL] [Abstract][Full Text] [Related]
73. [Evaluation of transcatheter hepatic segmental or subsegmental infusion of SMANCS for treatment of hepatocellular carcinoma].
Inoue Y; Tomoda K; Oi H; Nakamura H
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():56-63. PubMed ID: 9512689
[TBL] [Abstract][Full Text] [Related]
74. Antimetastatic and antitumor activity of a derivative of neocarzinostatin: an organic solvent- and water-soluble polymer-conjugated protein.
Maeda H; Takeshita J; Kanamaru R; Sato H; Khatoh J; Sato H
Gan; 1979 Oct; 70(5):601-6. PubMed ID: 160353
[TBL] [Abstract][Full Text] [Related]
75. Subcellular action of Neocarzinostatin. Intracellular incorporation, DNA breakdown and cytotoxicity.
Takeshita J; Maeda H; Koike K
J Biochem; 1980 Oct; 88(4):1071-80. PubMed ID: 6256337
[TBL] [Abstract][Full Text] [Related]
76. [A case of massive hepatoma which responded to SMANCS/Lipiodol regimen with intra-arterial infusion].
Kubo M; Fuchigami T; Murata S; Konno T; Maeda H
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2953-6. PubMed ID: 2551233
[TBL] [Abstract][Full Text] [Related]
77. [Combined treatment with intra-arterial administration of oily anti-cancer agents and transcatheter arterial embolization--clinical and pathological study on 2 cases with resected small hepatoma].
Tokuyama K; Jinno K; Yumoto Y; Takasima S; Fukuda K; Moriwaki S; Maeda H; Shimamura Y
Gan No Rinsho; 1984 Jul; 30(8):955-64. PubMed ID: 6088831
[TBL] [Abstract][Full Text] [Related]
78. [A case of giant hepatocellular carcinoma successfully treated by arterial administration of SMANCS].
Yajima Y; Miyazaki A; Miyasato S; Tomiya Y; Shibuya D; Ohira S; Sakurada H; Ishii K; Kinoshita T
Gan To Kagaku Ryoho; 1996 Sep; 23(10):1325-9. PubMed ID: 8831747
[TBL] [Abstract][Full Text] [Related]
79. Combined effect of radiation and YM-881 (SMANCS) on murine tumors and bone marrow.
Ono K; Wandl E; Sasai K; Tsutsui K; Shibamoto Y; Takahashi M; Abe M
Acta Oncol; 1990; 29(4):455-9. PubMed ID: 2143908
[TBL] [Abstract][Full Text] [Related]
80. Lymphotropic accumulation of an antitumor antibiotic protein, neocarzinostatin.
Maeda H; Takeshita J; Yamashita A
Eur J Cancer (1965); 1980 May; 16(5):723-31. PubMed ID: 6446456
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
